162 related articles for article (PubMed ID: 2963589)
1. Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives.
Legler G; Bieberich E
Arch Biochem Biophys; 1988 Jan; 260(1):427-36. PubMed ID: 2963589
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases.
Gopalan V; Daniels LB; Glew RH; Claeyssens M
Biochem J; 1989 Sep; 262(2):541-8. PubMed ID: 2508630
[TBL] [Abstract][Full Text] [Related]
3. Glucosylceramidase from calf spleen. Characterization of its active site with 4-n-alkylumbelliferyl beta-glucosides and N-alkyl derivatives of 1-deoxynojirimycin.
Legler G; Liedtke H
Biol Chem Hoppe Seyler; 1985 Dec; 366(12):1113-22. PubMed ID: 2936366
[TBL] [Abstract][Full Text] [Related]
4. Characterization of calf liver glucosidase I and its inhibition by basic sugar analogs.
Schweden J; Borgmann C; Legler G; Bause E
Arch Biochem Biophys; 1986 Jul; 248(1):335-40. PubMed ID: 2942110
[TBL] [Abstract][Full Text] [Related]
5. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
[TBL] [Abstract][Full Text] [Related]
6. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
Grabowski GA; Gatt S; Kruse J; Desnick RJ
Arch Biochem Biophys; 1984 May; 231(1):144-57. PubMed ID: 6426391
[TBL] [Abstract][Full Text] [Related]
7. Galactosylsphingosine inhibition of the broad-specificity cytosolic beta-glucosidase of human liver.
LaMarco KL; Glew RH
Arch Biochem Biophys; 1985 Feb; 236(2):669-76. PubMed ID: 3918500
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of a broad specificity beta-glucosidase from sheep liver.
Chinchetru MA; Cabezas JA; Calvo P
Int J Biochem; 1989; 21(5):469-76. PubMed ID: 2503402
[TBL] [Abstract][Full Text] [Related]
9. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
Donsimoni R; Legler G; Bourbouze R; Lalegerie P
Enzyme; 1988; 39(2):78-89. PubMed ID: 2969330
[TBL] [Abstract][Full Text] [Related]
10. Human lysosomal beta-glucosidase: purification by affinity chromatography.
Grabowski GA; Dagan A
Anal Biochem; 1984 Aug; 141(1):267-79. PubMed ID: 6437271
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of a naturally occurring beta-glucoside by a broad-specificity beta-glucosidase from liver.
LaMarco KL; Glew RH
Biochem J; 1986 Jul; 237(2):469-76. PubMed ID: 3099756
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of beta-glucosidase by imidazoles.
Li YK; Byers LD
Biochim Biophys Acta; 1989 Dec; 999(3):227-32. PubMed ID: 2532549
[TBL] [Abstract][Full Text] [Related]
14. Enzymic synthesis of alpha- and beta-D-glucosides of 1-deoxynojirimycin and their glycosidase inhibitory activities.
Asano N; Oseki K; Kaneko E; Matsui K
Carbohydr Res; 1994 May; 258():255-66. PubMed ID: 8039179
[TBL] [Abstract][Full Text] [Related]
15. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
[TBL] [Abstract][Full Text] [Related]
16. Purification by affinity chromatography of glucosidase I, an endoplasmic reticulum hydrolase involved in the processing of asparagine-linked oligosaccharides.
Hettkamp H; Legler G; Bause E
Eur J Biochem; 1984 Jul; 142(1):85-90. PubMed ID: 6235111
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of yeast exoglucanases by glucosidase inhibitors.
Ridruejo JC; Muñoz MD; Andaluz E; Larriba G
Biochim Biophys Acta; 1989 Dec; 993(2-3):179-85. PubMed ID: 2532041
[TBL] [Abstract][Full Text] [Related]
18. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.
Legler G; Bieberich E
Arch Biochem Biophys; 1988 Jan; 260(1):437-42. PubMed ID: 3124752
[TBL] [Abstract][Full Text] [Related]
19. Human acid beta-glucosidase: affinity purification of the normal placental and Gaucher disease splenic enzymes on N-alkyl-deoxynojirimycin-sepharose.
Osiecki-Newman KM; Fabbro D; Dinur T; Boas S; Gatt S; Legler G; Desnick RJ; Grabowski GA
Enzyme; 1986; 35(3):147-53. PubMed ID: 2944742
[TBL] [Abstract][Full Text] [Related]
20. Human acid beta-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active site.
Greenberg P; Merrill AH; Liotta DC; Grabowski GA
Biochim Biophys Acta; 1990 May; 1039(1):12-20. PubMed ID: 2141287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
